219 related articles for article (PubMed ID: 25128374)
21. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
22. Effective non-viral delivery of siRNA to acute myeloid leukemia cells with lipid-substituted polyethylenimines.
Landry B; Aliabadi HM; Samuel A; Gül-Uludağ H; Jiang X; Kutsch O; Uludağ H
PLoS One; 2012; 7(8):e44197. PubMed ID: 22952927
[TBL] [Abstract][Full Text] [Related]
23. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity.
Zintchenko A; Philipp A; Dehshahri A; Wagner E
Bioconjug Chem; 2008 Jul; 19(7):1448-55. PubMed ID: 18553894
[TBL] [Abstract][Full Text] [Related]
24. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS
Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582
[TBL] [Abstract][Full Text] [Related]
25. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
26. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
[TBL] [Abstract][Full Text] [Related]
27. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J
Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738
[TBL] [Abstract][Full Text] [Related]
28. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
Park K; Lee MY; Kim KS; Hahn SK
Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
[TBL] [Abstract][Full Text] [Related]
29. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine).
Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T
J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348
[TBL] [Abstract][Full Text] [Related]
30. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
31. Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers.
Aliabadi HM; Landry B; Bahadur RK; Neamnark A; Suwantong O; Uludağ H
Macromol Biosci; 2011 May; 11(5):662-72. PubMed ID: 21322108
[TBL] [Abstract][Full Text] [Related]
32. [Silence of VEGFR2 expression mediated by PEI/siRNA complexes].
Yang H; Che O; Chen S; Sun L; Ji AM
Yao Xue Xue Bao; 2010 May; 45(5):576-81. PubMed ID: 20931758
[TBL] [Abstract][Full Text] [Related]
33. Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine.
Shim MS; Kwon YJ
J Control Release; 2009 Feb; 133(3):206-13. PubMed ID: 18992289
[TBL] [Abstract][Full Text] [Related]
34. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
35. Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: a promising approach in liver-specific RNAi delivery.
Sajeesh S; Lee TY; Kim JK; Son DS; Hong SW; Kim S; Yun WS; Kim S; Chang C; Li C; Lee DK
J Control Release; 2014 Dec; 196():28-36. PubMed ID: 25251899
[TBL] [Abstract][Full Text] [Related]
36. Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes.
Hossain S; Stanislaus A; Chua MJ; Tada S; Tagawa Y; Chowdhury EH; Akaike T
J Control Release; 2010 Oct; 147(1):101-8. PubMed ID: 20620182
[TBL] [Abstract][Full Text] [Related]
37. 1,4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo.
Goyal R; Bansal R; Tyagi S; Shukla Y; Kumar P; Gupta KC
Mol Biosyst; 2011 Jun; 7(6):2055-65. PubMed ID: 21505659
[TBL] [Abstract][Full Text] [Related]
38. Phospholipid-modified polyethylenimine-based nanopreparations for siRNA-mediated gene silencing: implications for transfection and the role of lipid components.
Navarro G; Essex S; Sawant RR; Biswas S; Nagesha D; Sridhar S; de ILarduya CT; Torchilin VP
Nanomedicine; 2014 Feb; 10(2):411-9. PubMed ID: 23928214
[TBL] [Abstract][Full Text] [Related]
39. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers.
Zhu C; Jung S; Luo S; Meng F; Zhu X; Park TG; Zhong Z
Biomaterials; 2010 Mar; 31(8):2408-16. PubMed ID: 19963269
[TBL] [Abstract][Full Text] [Related]
40. Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis.
Duan J; Dong J; Zhang T; Su Z; Ding J; Zhang Y; Mao X
Nanomedicine (Lond); 2014 May; 9(6):789-801. PubMed ID: 24392891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
